Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Multileaf collimator Stories

2013-09-10 08:31:23

New system sets benchmark in radiation oncology versatility and capabilities BALTIMORE, Sept. 10, 2013 /PRNewswire/ -- The Johns Hopkins Department of Radiation Oncology and Molecular Radiation Sciences in the Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital (Baltimore, Maryland) has acquired Elekta's Versa HD(TM) linear accelerator. The radiation therapy system features the versatility to deliver high-volume conventional techniques, in addition to advanced linear...

2013-08-09 12:22:14

Survey respondents cite exceptional uptime ATLANTA, Aug. 9, 2013 /PRNewswire/ -- With a score of 93.1 out of 100, Elekta's Leksell Gamma Knife® Perfexion(TM) system earned the top ranking, receiving high marks for uptime, treatment times and planning speeds, according to KLAS research firm's recently released customer survey, Radiation Therapy 2013: Striving for Accuracy and Upgradeability*. Elekta Infinity(TM) radiation treatment system received the #2 ranking with a score of...

2013-04-18 08:32:22

New system sets benchmark in radiation oncology versatility and capabilities HOUSTON, April 18, 2013 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD(TM) linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the most advanced linear-accelerator...

2013-04-11 08:30:08

Groundbreaking linear accelerator provides single system versatility to deliver sophisticated treatments for more patients and cancer types ATLANTA, April 11, 2013 /PRNewswire/ -- Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD(TM) system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering...

2013-04-10 08:32:32

The Christie NHS Foundation Trust to harness new linear accelerator to improve therapy for patients with head-and-neck, lung and prostate cancers MANCHESTER, England, April 10, 2013 /PRNewswire/ -- Featuring a revolutionary combination of speed and accuracy, Elekta's new Versa HD(TM) system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to...

2012-11-01 07:32:11

SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife(®) M6((TM)) Series. The CyberKnife M6 Series features expanded clinical capabilities, reduced treatment times and an enhanced patient experience. The new CyberKnife M6 FIM and FM Systems, featuring the InCise(TM) Multileaf Collimator...

2012-10-28 11:20:17

SUNNYVALE, Calif. and BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO 2012 -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today launched its new TomoTherapy® H(TM) Series, featuring the TomoHDA(TM) System, with faster planning, faster delivery and increased quality. The TomoHDA System was unveiled at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston. Key features of the TomoHDA System include: Accuray's new TomoEDGE(TM)...

2012-07-25 02:31:09

ATLANTA and CHARLOTTE, N.C., July 25, 2012 /PRNewswire/ - AAPM Booth #845 - Elekta's Agility(TM)* multileaf collimator (MLC) will take center stage at Elekta's AAPM exhibit, July 29 - August 2 at the Charlotte Convention Center. Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Agility promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. Elekta recently received 510(k) clearance from the U.S....

2012-06-25 02:25:42

LEEDS, England, June 25, 2012 /PRNewswire/ -- A 51-year-old male became the first person to benefit from a radiation therapy technique that provides exceptional precision and high-speed delivery. Clinicians at St. James's University Hospital used Elekta's Agility(TM)* multileaf collimator (MLC) and Elekta Volumetric Modulated Arc Therapy (VMAT) to treat the patient's tongue cancer. The combination of the two innovations reduced the time it takes to deliver the radiation beams from...

2012-06-18 02:26:20

SALZBURG, Austria, June 18, 2012 /PRNewswire/ -- Requiring only a quick upgrade to their existing Elekta Synergy® linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility(TM)* 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care. Based...